10月26日 - 石药集团(1093.HK):*安尼妥单抗用于HER2阳性晚期胃癌的III期总生存期(OS)更新结果*安尼妥单抗组未出现治疗相关死亡;对照组为5例*更多公司报道:1093.HK
10月26日 - 石药集团(1093.HK):*安尼妥单抗用于HER2阳性晚期胃癌的III期总生存期(OS)更新结果*安尼妥单抗组未出现治疗相关死亡;对照组为5例*更多公司报道:1093.HK
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.